UK/EU Industry ‘Still Working In The Dark’ On Post-Brexit Regulation

Manufacturing & Northern Ireland The Most Taxing Issues

28 Sep 2020

As the final scheduled round of post-Brexit trade talks begins amid growing concern over the prospect of a deal and the pervasive threat of COVID-19, pharmaceutical industry bodies in the UK and the EU have issued an urgent call for an MRA on medicines GMP. They also want to see a one-year phase-in of medicines-related aspects of the Northern Ireland Protocol.

Man_Rushing_Clock — Time is running out to agree a UK/EU trade deal • Source: Shutterstock

Pharmaceutical industry bodies in the UK and the EU have called on the UK government and the European Commission to prioritize medicines in their negotiations on a trade deal, saying that companies are still “working in the dark” in critical areas of drug regulation, supply and safety reporting.

This week sees the start of the last scheduled round of trade talks, but issues such as fishing rights and...